Form 8-K - Current report:
SEC Accession No. 0000950170-24-123437
Filing Date
2024-11-07
Accepted
2024-11-07 16:35:07
Documents
13
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bioa-20241107.htm   iXBRL 8-K 45135
2 EX-99.1 bioa-ex99_1.htm EX-99.1 195950
3 GRAPHIC img161644396_0.jpg GRAPHIC 35241
  Complete submission text file 0000950170-24-123437.txt   415641

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bioa-20241107.xsd EX-101.SCH 24839
15 EXTRACTED XBRL INSTANCE DOCUMENT bioa-20241107_htm.xml XML 4701
Mailing Address 1445A SOUTH 50TH STREET RICHMOND CA 94804
Business Address 1445A SOUTH 50TH STREET RICHMOND CA 94804 510-806-1445
BioAge Labs, Inc. (Filer) CIK: 0001709941 (see all company filings)

EIN.: 474721157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42279 | Film No.: 241436444
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)